FDA Adverse Event Malfunction Summary report: N

ELECSYS ANTI-CCP

MDR report key: 23707771 · Received December 3, 2025

Report

Report Number
1823260-2025-04936
Event Type
Malfunction
Date Received
December 3, 2025
Date of Event
November 13, 2025
Report Date
December 18, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
NHX
PMA / PMN Number
K081338
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INVESTIGATION DETERMINED THE ISSUE IS CONSISTENT WITH HEMOLYSIS OF THE PATIENT SAMPLE. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT ISSUE.

Additional Manufacturer Narrative · 0

THE SERIAL NUMBER OF THE E411 ANALYZER WAS (B)(6). THE INVESTIGATION IS ONGOING.

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH ELECSYS ANTI-CCP ON A COBAS E411 RACK. THE SAMPLE INITIALLY RESULTED IN AN ANTI-CCP VALUE OF 50 U/ML. THE SAMPLE WAS DILUTED X 5 USING LOW CONCENTRATION PATIENT SERUM AND REPEATED, RESULTING IN AN ANTI-CCP VALUE OF 660 U/ML.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2787445 ELECSYS ANTI-CCP ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP) NHX ROCHE DIAGNOSTICS ASKU

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown